Schütz W, Kolassa N, Kraupp O
Pharmacology. 1975;13(2):143-54. doi: 10.1159/000136895.
The effects of the i.v. administration of inulin trinicotinate-monomethochloride (L-3) on haemodynamics, airway pressure and blood histamine levels were studied in chloralose-anaesthetized dogs and compared with the effects of compound 48/80. The control arterial histamine level was 0.041 plus or minus 0.002 mug/ml (mean plus or minus SEM) as determined by a fluorometric assay. L-3 (0.15 mg/kg) released high amounts of histamine, as indicated by a peak level in arterial histamine of 0.212 plus or minus 0.027 mug/ml within 3 min, which was not futher enhanced on increasing the dosage of L-3 to 1 mg/kg. After the i.v. injection of 0.15 mg/kg of 48/80 the peak level in arterial histamine was 0.146 plus or minus 0.008 mug/ml, and the level was further markedly elevated to 0.918 plus or minus 0.068 mug/ml after the administration of 1 mg/kg of 48/80. The concomitant fall in systemic blood pressure and the rise in airway pressure can be satisfactorily explained on the basis of histamine liberation. Whereas these parameters as well as the blood histamine concentration gradually returned to control values, the heart rate remained elevated during the observation period of 2 h. The arteriovenous differences in blood histamine across various tissues and organs following L-3 and 48/80 administration indicated histamine release mainly from skin and muscle and histamine uptake by the kidney, the digestive tract and to a lesser extent the lungs. The portal-hepatic vein differences revealed no consistent changes in liver histamine balance. As regards the lungs and liver, the present results suggest a dynamic equilibrium between histamine release and uptake in these organs in the intact animal. Both, L-3 and 48/80 elicited a similar pattern of histamine release and uptake. The extreme histamine releasing capacity of 1 mg/kg of 48/80 may be explained by an additional non-selective mechanism of histamine liberation.
在水合氯醛麻醉的犬中研究了静脉注射烟酸肌醇酯 - 一甲氯铵(L - 3)对血流动力学、气道压力和血液组胺水平的影响,并与化合物48/80的作用进行了比较。通过荧光测定法测定,对照动脉组胺水平为0.041±0.002微克/毫升(平均值±标准误)。L - 3(0.15毫克/千克)释放出大量组胺,如动脉组胺在3分钟内达到峰值水平0.212±0.027微克/毫升所示,增加L - 3剂量至1毫克/千克时并未进一步增强。静脉注射0.15毫克/千克的48/80后,动脉组胺峰值水平为0.146±0.008微克/毫升,给予1毫克/千克的48/80后,该水平进一步显著升高至0.918±0.068微克/毫升。基于组胺释放可以令人满意地解释伴随的全身血压下降和气道压力升高。虽然这些参数以及血液组胺浓度逐渐恢复到对照值,但在2小时的观察期内心率仍保持升高。给予L - 3和48/80后,不同组织和器官的血液组胺动静脉差异表明组胺主要从皮肤和肌肉释放,而肾脏、消化道以及程度较轻的肺摄取组胺。门静脉 - 肝静脉差异显示肝组胺平衡无一致变化。关于肺和肝,目前的结果表明在完整动物中这些器官的组胺释放和摄取之间存在动态平衡。L - 3和48/80均引发了类似的组胺释放和摄取模式。1毫克/千克的48/80的极端组胺释放能力可能由组胺释放的额外非选择性机制来解释。